GPLD1 and cancer: Based on our current understanding of potential targets for phosphoglyceride metabolism in cancer, inhibitors of the key enzymes including PLD, PLA1/2, PAP, DGAT1/2, and LPCATs have been explored in a series of studies.261, 262